EWM
CTIC

Edge Wealth Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Edge Wealth Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-800
Closed -$19K – 501
2014
Q4 		$19K Buy
+800
New +$18.5K 0.01% 263

Other funds holding CTIC

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Edge Wealth Management's CTIC Position: Q1 2015 in Review

Edge Wealth Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2015, closing a stake of 800 shares — an estimated $19K sold.

Edge Wealth Management first reported a position in CTIC in Q4 2014 and held it in 1 quarter. The position peaked at $19K in Q4 2014. 98 funds tracked by Wall St. Rank hold CTIC as of Q1 2015.

  • Edge Wealth Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2015 after selling out during the quarter.
  • Edge Wealth Management sold 800 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2015, an estimated $19K.
  • Edge Wealth Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2014 and held it in 1 quarter.
  • Edge Wealth Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $19K in Q4 2014.
  • 98 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2015.

Based on Edge Wealth Management's 13F filing for Q1 2015, filed 6 Apr 2015.